These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5514413)

  • 1. Some quantitative behavioural changes in L-dopa therapy.
    Meier MJ; Baker AB; Martin WE
    Trans Am Neurol Assoc; 1970; 95():64-8. PubMed ID: 5514413
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative effects of L-dopa on different types of movements and muscle tone in Parkinsonian patients.
    Knutsson E; Mårtensson A
    Scand J Rehabil Med; 1971; 3(3):121-30. PubMed ID: 5156174
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 6. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 8. Some quantitative behavioral changes in L-dopa therapy.
    Meier MJ; Baker AB; Martin WE
    Geriatrics; 1972 Jun; 27(6):89-97. PubMed ID: 5032486
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychomotor performances of patients undergoing L-dopa therapy.
    Davis LJ; Muenter MD
    Percept Mot Skills; 1971 Dec; 33(3):1303-8. PubMed ID: 5160051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of L-DOPA in the therapy of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G
    Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral L-dopa in the modern therapy of parkinsonian syndromes: general considerations; analysis of the first 50 personal cases].
    Guidetti B; Giuffrè R
    Sist Nerv; 1970; 22(2):196-202. PubMed ID: 5504557
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism.
    Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L
    Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA; Campanella G
    Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
    Gauthier G; de Ajuriaguerra J; Simona B; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Rev Neurol (Paris); 1970 Nov; 123(5):297-319. PubMed ID: 5513630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parkinson's disese. Treatment with L-dopa].
    Herskovits E; Matera R
    Prensa Med Argent; 1969 Oct; 56(35):1674-80. PubMed ID: 5399419
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU; Stam FC; Meerlo HJ
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):701-7. PubMed ID: 5551426
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in fine motor control in Parkinson patients following levodopa.
    Marsh GG; Kravitz EA
    Percept Mot Skills; 1971 Aug; 33(1):211-5. PubMed ID: 5095787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.